Compare Lustrum:ROHTO PHARMACEUTICAL CO.,LTD.:4527

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index ROHTO PHARMACEUTICAL CO.,LTD. Go to web site 4527 Medicals 東証プライム March 1, 2000 1961.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

ROHTO PHARMACEUTICAL CO.,LTD. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

ROHTO PHARMACEUTICAL CO.,LTD. Balance Sheet 2024年3月期 ROHTO PHARMACEUTICAL CO.,LTD. Balance Sheet 2023年3月期 ROHTO PHARMACEUTICAL CO.,LTD. Balance Sheet 2022年3月期 ROHTO PHARMACEUTICAL CO.,LTD. Balance Sheet 2021年3月期 ROHTO PHARMACEUTICAL CO.,LTD. Balance Sheet 2020年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Cash and Cash Equivalents
(Percent)
89,210up
(25.8%)down
79,951up
(25.8%)down
72,791up
(26.5%)up
52,964up
(23.4%)up
45,307
(21.0%)
Other Current AssetsHelp
(Percent)
125,549up
(36.3%)up
110,295up
(35.6%)up
91,515up
(33.3%)down
80,107down
(35.4%)down
85,399
(39.6%)
Tangible Fixed AssetsHelp
(Percent)
68,607up
(19.8%)down
66,182up
(21.4%)down
62,839up
(22.9%)up
49,790up
(22.0%)down
48,539
(22.5%)
Intangible Fixed AssetHelp
(Percent)
6,932down
(2.0%)down
6,997up
(2.3%)down
6,587up
(2.4%)up
4,590up
(2.0%)up
2,685
(1.2%)
Investments and OthersHelp
(Percent)
53,592up
(15.5%)up
43,688up
(14.1%)up
38,190up
(13.9%)down
35,394up
(15.7%)up
31,269
(14.5%)
Total AssetsHelp
(Percent)
346,175
(100%)
309,677
(100%)
274,876
(100%)
226,149
(100%)
215,644
(100%)
Total Current LiabilitiesHelp
(Percent)
94,659up
(27.3%)down
92,591up
(29.9%)down
83,126up
(30.2%)up
64,454down
(28.5%)down
71,171
(33.0%)
Total Long-term LiabilitiesHelp
(Percent)
5,190down
(1.5%)down
7,516down
(2.4%)down
13,350up
(4.9%)up
5,787up
(2.6%)up
5,190
(2.4%)
Shareholder's EquityHelp
(Percent)
246,326up
(71.2%)up
209,570up
(67.7%)up
178,400up
(64.9%)down
155,908up
(68.9%)up
139,283
(64.6%)
Total LiabilitiesHelp
(Percent)
346,175
(100%)
309,677
(100%)
274,876
(100%)
226,149
(100%)
215,644
(100%)

ROHTO PHARMACEUTICAL CO.,LTD. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

ROHTO PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2024年3月期 ROHTO PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2023年3月期 ROHTO PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2022年3月期 ROHTO PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2021年3月期 ROHTO PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2020年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Amount of Sales
(Percent)
270,840
(100%)
238,664
(100%)
199,646
(100%)
181,287
(100%)
188,327
(100%)
Total Sales
(Percent)
270,840
(100%)
238,664
(100%)
199,646
(100%)
181,287
(100%)
188,327
(100%)
Cost of SalesHelp
(Percent)
113,554up
(41.9%)down
101,243up
(42.4%)up
83,476up
(41.8%)up
74,326up
(41.0%)up
74,135
(39.4%)
Other Costs and RevenueHelp 126,348up
(46.7%)up
111,043up
(46.5%)down
95,042up
(47.6%)down
90,218down
(49.8%)down
98,783
(52.5%)
Total CostsHelp 239,902 212,286 178,518 164,544 172,918
Net RevenueHelp 157,286up
(58.1%)up
137,421up
(57.6%)down
116,170up
(58.2%)down
106,961down
(59.0%)down
114,192
(60.6%)
Earnings Before TaxHelp 41,518up
(15.3%)up
34,290up
(14.4%)up
27,874up
(14.0%)up
23,006up
(12.7%)up
21,730
(11.5%)
Net IncomeHelp 30,938up
(11.4%)up
26,378up
(11.1%)up
21,128up
(10.6%)up
16,743up
(9.2%)up
15,409
(8.2%)
当期純利益 30,938 26,378 21,128 16,743 15,409

ROHTO PHARMACEUTICAL CO.,LTD. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

ROHTO PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2024年3月期 ROHTO PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2023年3月期 ROHTO PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2022年3月期 ROHTO PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2021年3月期 ROHTO PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2020年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Operating Cash Flow(OFC)Help
(Percent)
34,268up
(87.9%)up
30,925up
(85.5%)up
27,251up
(77.7%)down
20,077up
(99.5%)down
19,109
(100.0%)
Investing Cash Flow(ICF)Help
(Percent)
-16,317down
(-41.9%)down
-13,176up
(-36.4%)up
-16,406down
(-46.8%)up
-10,237down
(-50.7%)down
-9,405
(-49.2%)
Financing Cash FlowHelp
(Percent)
-13,784up
(-35.4%)up
-16,199down
(-44.8%)down
3,470up
(9.9%)up
-2,347down
(-11.6%)down
-1,603
(-8.4%)
Exchange Difference of Cash and Cash EquivalentsHelp
(Percent)
4,703down
(12.1%)down
5,236up
(14.5%)up
4,335up
(12.4%)up
96up
(0.5%)up
-781
(-4.1%)
Net Increase and Decrease in Cash and Cash Equivalentsn 8,870up
(22.8%)up
6,786down
(18.8%)down
18,650up
(53.2%)up
7,589up
(37.6%)down
7,320
(38.3%)

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

ROHTO PHARMACEUTICAL CO.,LTD.

Company where related level is highHelp

GNI Group Ltd.
BrightPath Biotherapeutics Co., Ltd.
Modalis Therapeutics Corporation
Mitsubishi Tanabe Pharma Corporation
EIKEN CHEMICAL CO.,LTD.
TMS Co.,Ltd.
SAWAI GROUP HOLDINGS Co., Ltd.
KAKEN PHARMACEUTICAL CO.,LTD.
Cyfuse Biomedical K.K.
Oncolys BioPharma Inc.